World's Best Scientists 2026 revealed!
Timothy R. Rebbeck

Timothy R. Rebbeck

D-Index & Metrics

Medicine

D-Index
121
Citations
63929
World Ranking
3566
National Ranking
1962

Overview

Timothy R. Rebbeck is affiliated with Harvard University in the United States. Their research primarily focuses on medicine, with significant contributions in pulmonary and respiratory medicine, oncology, immunology, dermatology, and radiology, nuclear medicine, and imaging.

The scientist's work addresses several key topics, including:

  • Cutaneous Melanoma Detection and Management
  • Immunotherapy and Immune Responses
  • Prostate Cancer Diagnosis and Treatment
  • Prostate Cancer Treatment and Research
  • Skin Protection and Aging
  • CAR-T cell therapy research
  • Cardiac Imaging and Diagnostics

A selection of recent publications includes:

  • Comparison of community pathologists with expert dermatopathologists evaluating Breslow thickness and histopathologic subtype in a large international population-based study of melanoma, 2021, JAAD International
  • Sex differences in melanoma survival-a GEM study, 2025, JNCI Cancer Spectrum
  • Can magnetic resonance imaging safely replace a confirmatory biopsy in patients on active surveillance for prostate cancer?, 2025, Journal of Clinical Oncology
  • Genome-Wide Association Studies, Field Synopses, and the Development of the Knowledge Base on Genetic Variation and Human Diseases, 2020, UNC Libraries
  • Abstract 1182: Association of prostate cancer candidate genes with overall and aggressive prostate cancer in men of African ancestry, 2023, Cancer Research

Frequent co-authors collaborating with Timothy R. Rebbeck include:

  • Marianne Berwick
  • Li Luo
  • Klaus J. Busam
  • Anne Ε. Cust
  • Roberto Zanetti

The scientist commonly publishes in these venues:

  • Journal of Clinical Oncology
  • JNCI Cancer Spectrum
  • JAAD International
  • UNC Libraries
  • Cancer Research

Best Publications

  • Genetic Heterogeneity and Penetrance Analysis of the BRCA1 and BRCA2 Genes in Breast Cancer Families

    D Ford;D F Easton;M Stratton;S Narod

  • Prophylactic Oophorectomy in Carriers of BRCA1 or BRCA2 Mutations

    Timothy R. Rebbeck;Henry T. Lynch;Susan L. Neuhausen;Steven A. Narod

  • Association of Risk-Reducing Surgery in BRCA1 or BRCA2 Mutation Carriers With Cancer Risk and Mortality

    Susan M. Domchek;Tara M. Friebel;Christian F. Singer;D. Gareth Evans

  • Bilateral Prophylactic Mastectomy Reduces Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers: The PROSE Study Group

    Timothy R. Rebbeck;Tara Friebel;Henry T. Lynch;Susan L. Neuhausen

  • Metabolic gene polymorphism frequencies in control populations.

    S. Garte;L. Gaspari;A.K. Alexandrie;C. Ambrosone

  • Meta-analysis of Risk Reduction Estimates Associated With Risk-Reducing Salpingo-oophorectomy in BRCA1 or BRCA2 Mutation Carriers

    Timothy R. Rebbeck;Noah D. Kauff;Susan M. Domchek

  • Menarche, menopause, and breast cancer risk: Individual participant meta-analysis, including 118 964 women with breast cancer from 117 epidemiological studies

    N. Hamajima;K. Hirose;K. Tajima;T. Rohan

  • Molecular epidemiology of the human glutathione S-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility.

    T R Rebbeck

  • Cancer Risk Estimates for BRCA1 Mutation Carriers Identified in a Risk Evaluation Program

    Marcia S. Brose;Timothy R. Rebbeck;Kathleen A. Calzone;Jill E. Stopfer

  • BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer.

    Couch Fj;DeShano Ml;Blackwood Ma;Calzone K

  • Type I and II Endometrial Cancers: Have They Different Risk Factors?

    Veronica Wendy Setiawan;Hannah P. Yang;Malcolm C. Pike;Malcolm C. Pike;Susan E. McCann;Susan E. McCann

  • Breast Cancer Risk After Bilateral Prophylactic Oophorectomy in BRCA1 Mutation Carriers

    Timothy R. Rebbeck;Albert M. Levin;Andrea Eisen;Carrie Snyder

  • Pathology of Breast and Ovarian Cancers among BRCA1 and BRCA2 Mutation Carriers: Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA).

    Nasim Mavaddat;Daniel Barrowdale;Irene L. Andrulis;Susan M. Domchek

  • Risk-Reducing Salpingo-Oophorectomy for the Prevention of BRCA1- and BRCA2-Associated Breast and Gynecologic Cancer: A Multicenter, Prospective Study

    Noah D. Kauff;Susan M. Domchek;Tara M. Friebel;Mark E. Robson

  • Comprehensive Genomic Characterization of Long Non-coding RNAs across Human Cancers

    Xiaohui Yan;Xiaohui Yan;Zhongyi Hu;Yi Feng;Xiaowen Hu

  • Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer

    Stig E. Bojesen;Stig E. Bojesen;Karen A. Pooley;Sharon E. Johnatty;Jonathan Beesley

  • Modification of Clinical Presentation of Prostate Tumors by a Novel Genetic Variant in CYP3A4

    Timothy R. Rebbeck

  • Approaching Health Disparities From a Population Perspective: The National Institutes of Health Centers for Population Health and Health Disparities

    Richard B. Warnecke;April Oh;Nancy Breen;Sarah Gehlert

  • Assessment of cumulative evidence on genetic associations: interim guidelines

    John P A Ioannidis;Paolo Boffetta;Julian Little;Thomas R O'Brien

  • Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence

    N. Hamajima;K. Hirose;K. Tajima;T. Rohan

Frequent Co-Authors

Susan M. Domchek
Susan M. Domchek University of Pennsylvania
Katherine L. Nathanson
Katherine L. Nathanson University of Pennsylvania
Judy Garber
Judy Garber Harvard University
Douglas F. Easton
Douglas F. Easton University of Cambridge
Amanda B. Spurdle
Amanda B. Spurdle QIMR Berghofer Medical Research Institute
Esther M. John
Esther M. John Stanford University
Fergus J. Couch
Fergus J. Couch Mayo Clinic
Susan L. Neuhausen
Susan L. Neuhausen City Of Hope National Medical Center
Irene L. Andrulis
Irene L. Andrulis University of Toronto

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring career options in healthcare doesn’t always mean following a single route like traditional med school. Many students are interested in upskilling through alternative degrees and flexible programs that offer new opportunities. For example, nurses seeking advanced qualifications might be interested in a dnp program without clinical hours, which can save time and allow for continued professional growth without the heavy clinical requirements.

If you’re interested in entering the workforce quickly, you may ask, what is the fastest way to become an lpn? Fast-track LPN programs online are designed to help you qualify for entry-level nursing positions in as little as a year.

Mental health is a growing field, and for those wanting to specialize, a fast track mental health nursing degree can help you become a Psychiatric Mental Health Nurse Practitioner, opening opportunities to work in clinics, schools, or private practice.

For those interested in the management side of healthcare, a health administration degree online can qualify you for roles that shape the future of hospitals, clinics, and healthcare systems. All these pathways can help you tailor your medical education to your interests and lifestyle.

Best Scientists Citing Timothy R. Rebbeck

Trending Scientists

Recently Published Articles